Title: Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver
fibrosis
Version: 2 Date: 24 Dec 2023
Reviewer:  Hirotoshi Ebinuma
Reviewer's report:
This resubmitted  manuscript is  commendable in that authors adequately answer against the
reviewers' questions, but unfortunately does not provide any new findings.
The finding that soluble suppression of tumorigenicity 2 may be utilized as a new marker of
liver fibrosis is appreciated, so this manuscript is worthwhile to accept to publish, although the
number of cases is small and liver biopsy was not performed.
Title: Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver
fibrosis
Version: 2 Date: 24 Dec 2023
Reviewer:  Hirotoshi Ebinuma
Reviewer's report:
This resubmitted  manuscript is  commendable in that authors adequately answer against the
reviewers' questions, but unfortunately does not provide any new findings.
The finding that soluble suppression of tumorigenicity 2 may be utilized as a new marker of
liver fibrosis is appreciated, so this manuscript is worthwhile to accept to publish, although the
number of cases is small and liver biopsy was not performed.
Please review this paper.
user
Title: Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver
fibrosis
Version: 2 Date: 24 Dec 2023
Reviewer:  Hirotoshi Ebinuma
Reviewer's report:
This resubmitted  manuscript is  commendable in that authors adequately answer against the
reviewers' questions, but unfortunately does not provide any new findings.
The finding that soluble suppression of tumorigenicity 2 may be utilized as a new marker of
liver fibrosis is appreciated, so this manuscript is worthwhile to accept to publish, although the
number of cases is small and liver biopsy was not performed.
assistant